GLP-1 receptor agonists are injectable medications that regulate blood glucose and reduce appetite by mimicking natural GLP-1 hormone Common UK medications include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro) NHS access for diabetes follows NICE guidance with minimal prescription costs, whilst weight management access through NHS specialist services remains limited Private treatment costs exclude additional fees for consultations, monitoring, and blood tests which can add 130450 to initial expenses Current national supply constraints may affect availability and pricing across both NHS and private providers Patients should only use GPhC-registered pharmacies and CQC-regulated services, avoiding unregulated sources due to counterfeit medication risks Table of Contents What Are GLP-1 Medications and How Do They Work

This is the idea "that doctors, if they're not prescribing what you ask for or they're not offering you these solutions, are acting as a barrier to your good health." Stacking Up McGuire, Cushman and colleagues published a review last year on one peptide they encountered frequently: BPC-157
GLP-1s are serious medications with certain potential toxicities for some patients, including pancreatitis, thyroid cancer, and very rarely, but now officially acknowledged in the case of Wegovy blindness, caused by a condition called non-arteritic anterior ischemic optic neuropathy (NAION)
Its particularly popular among athletes and individuals recovering from injuries